Journal article
Cellular prion protein expression is not regulated by the Alzheimer's amyloid precursor protein intracellular domain
V Lewis, IJ Whitehouse, H Baybutt, JC Manson, SJ Collins, NM Hooper
Plos One | PUBLIC LIBRARY SCIENCE | Published : 2012
Abstract
There is increasing evidence of molecular and cellular links between Alzheimer's disease (AD) and prion diseases. The cellular prion protein, PrP C, modulates the post-translational processing of the AD amyloid precursor protein (APP), through its inhibition of the β-secretase BACE1, and oligomers of amyloid-β bind to PrP C which may mediate amyloid-β neurotoxicity. In addition, the APP intracellular domain (AICD), which acts as a transcriptional regulator, has been reported to control the expression of PrP C. Through the use of transgenic mice, cell culture models and manipulation of APP expression and processing, this study aimed to clarify the role of AICD in regulating PrP C. Over-expres..
View full abstractRelated Projects (2)
Grants
Awarded by UK Research and Innovation
Funding Acknowledgements
The authors gratefully acknowledge the financial support of the Medical Research Council (G0802189 to NMH) and Alzheimer's Research UK (NMH and JCM). VL is supported by NHMRC (National Health and Medical Research Council) Training Fellowship (#567123). SJC is supported by NHMRC Practitioner Fellowship (#400183). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.